You just read:

Statement by Peter Marks, M.D., Ph.D., director of FDA's Center for Biologics Evaluation and Research, on data accuracy issues with recently approved gene therapy

News provided by

U.S. Food and Drug Administration

Aug 06, 2019, 12:49 ET